Top US Pharma Chooses Thought Leader Select for Obesity Centers of Excellence Initiative

October 18, 2012 · Leave a comment

October 18, 2012 (CHAPEL HILL, NC)  Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.

Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »

TAGS: basic research  biopharmaceutical industry  biotechnology  Brian Castle  centers of excellence identification  centers of excellence profiling  centers of excellence strategy  clinical pharmacists  clinical research  drug development  endocrinology  health care professionals  key opinion leaders  KOL identification  KOL profiling  KOL strategy  long-term care  medical device industry  medical diagnostics  medical researchers  medical schools  medical science  medical science liaison outreach  nursing  obesity  obesity centers of excellence  obesity KOLs  patient care  pharmaceuticals  pharmacy  physician assistants  physicians  primary care medicine  registered nurses  scientific journal publishing  specialty medical clinics  teaching hospitals  Thought Leader Select  Thought Leader Select consulting group  Thought Leader Select research group  treatment guidelines  type 1 diatbetes  type 2 diabetes  universities

Thought Leader Select Announces New Assessments of Key Opinion Leaders, Centers of Excellence in Women’s Health, Oncology

October 28, 2011 · Leave a comment

Company News

Thought Leader Select is pleased to announce a pair of projects in support of a top 10 global biopharmaceutical company as it seeks to develop a portfolio of medicines in women’s health.

For the assessments, Thought Leader Select will study key opinion leaders and medical centers of excellence in the treatment of cancers affecting the gynecological health of women, specifically ovarian cancer, cervical cancer, and uterine cancer. In the first assessment, the company will identify and profile Canadian oncologists with vast expertise in research and treatment of these cancers affecting women.  In the second assessment, Thought Leader Select will identify and profile Canadian medical centers with specialized infrastructures for research and treatment in these disease areas.

“We are very proud to begin this critical work supporting pharmaceutical development in the area of women’s health,” stated Neil Mellor, Thought Leader Select’s global business development consultant.  “This client is an established leader in developing medicines for the treatment of various forms of cancer, and we appreciate the opportunity to help them partner with the right key opinion leaders and centers of excellence in women’s health and oncology, to ultimately help patients suffering from these cancers.”

TAGS: biopharmaceutical companies  cancers affecting women  centers of excellence identification  centers of excellence profiling  cervical cancer  clinical research  doctors  gynecology  key opinion leaders  KOL identification  KOL profiling  KOLs  medical centers of excellence  medical experts  medicine  oncologists  Oncology  ovarian cancer  patients  pharmaceutiucals  physicians  Thought Leader Select  thought leaders  uterine cancer  women's health